For instance, metformin activates the AMPK/SIRT1/mTOR pathway, reduces oxidative stress, promotes autophagy, and inhibits apoptosis, thereby exhibiting therapeutic effects on non-alcoholic fatty liver disease [4]. This evidence concerns the gene MTOR and metabolic dysfunction-associated steatotic liver disease.